Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP <div class="row"> <div class="col-md-12"> <p>Indian Journal of Clinical Practice is the flagship peer-reviewed journal of IJCP Group<br />A multispecialty journal, it provides clinicians with evidence-based updated information about a diverse range of common medical topics, including those frequently encountered by the Indian physician, to make informed clinical decisions.<br /><br />Indian Journal of Clinical Practice is a peer-reviewed journal that publishes original research, clinical reviews, case reports, expert viewpoints, clinical practice guidelines, Medilaw, Medifinance, Spiritual Update, Lighter reading including latest news and updates in medicine from around the globe.<br /><br />Indian Journal of Clinical Practice has been published regularly every month since it was first launched in June 1990 as a monthly medical journal.<br /><br />The journal is available in print and is also available online. The ISSN (print version) number is 0971-0876; RNI number is 50798/1990.<br /><br />Indian Journal of Clinical Practice is indexed with Indian Citation Index and IndMed (http://indmed.nic.in/).</p> <p>IJCP Group was founded in 1990 by Padma Shri and Dr BC Roy National Awardee Dr KK Aggarwal and was the pioneer of medical journalism in India. It was started with the basic objective of updating the knowledge of the medical professionals, which is the need of the hour. We began with a single monthly journal called ‘The Indian Journal of Clinical Practice’ launched in 1990 by Late Dr Shankar Dayal Sharma, the then Vice President of India. Since then we have now grown into various multispecialty journals, customized books and publications, events, consulting, branding, Continuing Medical Education (CME) activities, doctor meetings, Key Opinion Leader (KOL) interactions, etc.</p> </div> </div> <div class="row"> <div class="col-md-12"><strong><span id="ctl00_ContentPlaceHolder1_Label2">Aim &amp; Mission</span></strong></div> </div> <div class="row"> <div class="col-md-12"> <p><br /><strong>Our Aim</strong><br />To help medical professionals both within India and abroad to stay updated with the latest advances in medicine and help improve patient outcomes and to provide a platform for doctors to share information<br /><br /><strong>Our Mission</strong><br />To be the leader in the field of medical communications and to make Indian medical literature vastly read within India and abroad.<br /><br /><strong>Our Vision</strong><br />To benchmark the kaleidoscope of medical information<br /><br /><strong>Our Guiding Principles</strong><br />Content is King, commitment, excellence, quality, timeline efficiency, creativity, innovation</p> </div> </div> en-US tanuja@ijcpgroup.com (Tanuja Bisht) journalmanager@ijcpgroup.com (Journal Manager) Fri, 24 May 2024 08:00:37 +0000 OJS 3.3.0.14 http://blogs.law.harvard.edu/tech/rss 60 From Evidence to Practice: Denosumab in Osteoporosis and Joint Health https://ojs.ijcp.in/IJCP/article/view/996 <p>Osteoporosis and osteopenia are prevalent conditions in India, particularly among postmenopausal women and the elderly,<br>leading to increased fracture risks and morbidity. Denosumab, a monoclonal antibody, demonstrates superior efficacy<br>over other treatments in reducing fracture risk and enhancing bone mineral density (BMD). Clinical trials highlight its<br>effectiveness in preventing periprosthetic bone loss, improving implant stability, and mitigating femoral head collapse in<br>various conditions; combination therapies involving denosumab further amplify BMD gains and reduce fracture risk. The<br>article reviews the efficacy and safety of denosumab in managing osteoporosis, joint replacement therapy, and avascular<br>necrosis based on a review of clinical evidence and studies. Denosumab emerges as a cornerstone therapy for osteoporosis<br>management, offering multifaceted benefits in fracture prevention, joint replacement therapy, and avascular necrosis.</p> Dr SANJAY AGARWALA,, Dr NIRAD VENGSARKAR,, Dr HEMANT BHANDARI,, Dr SHUBRHANSHU SHEKHAR MOHANTY, Dr PRADEEP BHOSALE, Dr KAMAL BACHANI, Dr SANJAY YADAV, Dr YADAV, Dr VIJAY GONI, Dr ANIL MEHTANI, Dr SUBHASH JEHNAGIR, Dr SUDHIR SETH Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/996 Fri, 24 May 2024 00:00:00 +0000 Role of Sodium Alginate in Gastroesophageal Reflux Disease: An Overview https://ojs.ijcp.in/IJCP/article/view/1004 <p>Sodium alginate helps manage and treat heartburn and gastroesophageal reflux disease (GERD). This article discusses the<br>structure, mechanism of action and clinical application. A brief review of the literature is carried out.</p> Dr JYOTI YADAV, Dr SHUBHRICA Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1004 Mon, 03 Jun 2024 00:00:00 +0000 Medicine Update https://ojs.ijcp.in/IJCP/article/view/999 <p>EDITORIAL</p> Dr Veena Aggarwal Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/999 Mon, 03 Jun 2024 00:00:00 +0000 Health and Harmony: Teamwork is the Key https://ojs.ijcp.in/IJCP/article/view/1000 <p>GUEST EDITORIAL</p> Dr Sanjay Kalra, Dr Hitesh Punyani, Dr Suneet Verma, Dr Nitin Kapoor Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1000 Mon, 03 Jun 2024 00:00:00 +0000 Clinical Spectrum of Recurrent Urinary Tract Infections: A Single-Center Study https://ojs.ijcp.in/IJCP/article/view/1001 <p>A retrospective observational study was undertaken to evaluate the clinical profile of recurrent urinary tract infections (UTIs)<br>in a tertiary care hospital. Patients &lt;18 years, kidney-transplant recipients, those on immunosuppressive agents and pregnant<br>patients were excluded. Patients with ≥2 episodes of culture positive UTIs were included. Demographic details, investigations<br>and treatment were recorded. Out of total 48 patients, 18 were female and 30 male. The common manifestations were acute<br>pyelonephritis (52%), emphysematous pyelonephritis (20%) and cystitis (25%). Extended-spectrum beta-lactamase (ESBL)-<br>producing Escherichia coli (48%) was the most frequent organism isolated followed by Klebsiella spp. (29%) and Pseudomonas<br>spp. (23%). Recurrent episodes of UTI with same organisms were noted in 62% patients. Death occurred in 12.5% patients<br>due to septic shock. Renal calculi (24%) and double J (DJ) stent placement (30%) were associated with recurrent UTIs,<br>though this was not statistically significant. Resistance to higher antibiotics (colistin, carbapenems, piperacillin-tazobactam,<br>cefoperazone-sulbactam, third-generation cephalosporins) (65.4%, r = 0.81), diabetes (62.5%, r = 0.79), urological procedure<br>(39.5%, r = 0.68), prior hospitalization (75%, r = 0.84), history of UTI prior to the study period (44%, r = 0.72) and need for<br>per urethral catheter (PUC) beyond 7 days (35%, r = 0.74) had significant correlation with recurrent UTIs.</p> Dr Durga Deorukhkar, Dr HARDIK SHAH, Dr DILIP KIRPALANI, Dr SHRIRANG BICHU, Dr ASHOK KIRPALANI¥ Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1001 Mon, 03 Jun 2024 00:00:00 +0000 Navigating Choices: A Questionnaire-based Study on Usage of Antiplatelet Therapies in Management of Acute Coronary Syndrome in India https://ojs.ijcp.in/IJCP/article/view/1003 <p>Percutaneous coronary intervention (PCI) is a common invasive cardiac procedure used to treat acute coronary<br>syndrome (ACS). The main objective of anticoagulant therapy in PCI is to minimize the risk of plaque rupture and decrease<br>the formation of blood clots. Understanding clinicians' prescription patterns is crucial for optimizing treatment strategies<br>for patients with ACS who have undergone PCI. Methods: It was a cross-sectional, questionnaire-based, noninterventional<br>study which included questionnaire responses from 136 cardiologists, regarding usage of antiplatelets in ACS management.<br>Results: Ticagrelor and aspirin dual antiplatelet therapy (DAPT) is favored by 54% cardiologists in managing ACS patients<br>who have undergone PCI, regardless of the presence or absence of type 2 diabetes mellitus (T2DM). Further, 78% of the<br>participants preferred long-term DAPT over short-term and medium-term alternatives. Forty percent respondents preferred<br>a 1-month triple antithrombotic therapy (TAT) for PCI patients with atrial fibrillation. Additionally, the study emphasized<br>the importance of considering factors like age, bleeding history, hemoglobin, and creatinine clearance in determining the<br>optimal antithrombotic strategy. Conclusion: This study contributes valuable insights into the real-world practices of health<br>care practitioners, paving the way for more informed and personalized ACS management strategies in Indian patients.</p> Dr PRAFULLA KERKAR, Dr JAYESH PRAJAPATI, Dr PK SAHOO, Dr PANKAJ RASTOGI, Dr SUNIP BANERJEE¥, Dr SAUMITRA RAY, Dr BHUPEN DESAI, Dr SUNIL SATHE, Dr JOHANN CHRISTOPHER, Dr NARAYANA MURTHY, Dr CHETAN SHAH, Dr MAYUR MAYABHATE, Dr JESSICA DALI Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1003 Mon, 03 Jun 2024 00:00:00 +0000 Clinical Outcomes of Slow versus Rapid Enteral Feeding Advancement in Very Low Birth Weight Neonates at a Tertiary Care Center https://ojs.ijcp.in/IJCP/article/view/1005 <p>In India, every year around 3.5 million babies are born premature, accounting for almost 13% of total live<br>births in the country as compared to 5% to 7% incidence in the West. Preterm is defined as babies born before 37 weeks of<br>pregnancy. The rapidity of feed volume increments involves controversies like faster weight gain, shorter hospital stays, the<br>risk of necrotizing enterocolitis and vice versa. Methods: The present study was a randomized controlled trial conducted from<br>June 1, 2018 to October 31, 2019. All infants in the study were randomized to slow and rapid feeding protocols by a stratified<br>block randomization sequence of 2, 4, 6 blocks. Group 1 or the slow advancement group included 64 newborns babies and<br>Group 2 or the rapid advancement group included 69 newborns babies. Results: The average weight gain in Group 1 was<br>4.41 ± 0.9 g and in Group 2 it was 6.33 ± 1.3 g, the difference was statistically significant (p &lt; 0.02). Sixty out of 64 newborns<br>regained birth weight within 16.87 ± 0.9 days in Group 1, while 64 out of 69 newborns regained birth weight within 13.63 ±<br>0.9 days in Group 2. The difference was statistically significant. Increment in the mean occipitofrontal circumference per<br>week was 0.29 ± 0.27 cm Group 1, while in Group 2 it was 0.42 ± 0.05 cm; the difference was statistically significant. Mean<br>average length increment per week was found to be 0.55 ± 0.04 cm and 0.69 ± 0.05 cm in Group 1 and Group 2, respectively,<br>the difference was statistically significant (p &lt; 0.005). The mean duration of hospital stay was 27.47 ± 3.33 days in Group 1<br>while in Group 2, the duration of stay was 23.15 ± 2.22 days, the difference was statistically significant. Conclusion: Our<br>study supports enteral nutrition by rapid enteral feeding regimen in stable preterm neonates with very low birth weight</p> Dr RAJESH KUMAR MEENA, Dr DHAN RAJ BAGRI, Dr REENA KUMARI MEENA, Dr JAGDISH SINGH, Dr CHETAN MEENA Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1005 Mon, 03 Jun 2024 00:00:00 +0000 An Interesting Case of Pulmonary Tuberculosis with Hypoxemic Respiratory Failure Mimicking Interstitial Lung Disease https://ojs.ijcp.in/IJCP/article/view/1007 <p>Hypoxemic respiratory failure is a rare presentation of active pulmonary tuberculosis (TB). Though tuberculous acute<br>respiratory distress syndrome (ARDS) is well documented in medical literature, non-ARDS respiratory failure is seldom<br>reported in active pulmonary TB. We herein report a case, which posed a diagnostic dilemma as it clinically mimicked<br>interstitial lung disease. Imaging showed unilateral localized smooth interlobular septal thickening along with consolidation<br>without significant mediastinal lymphadenopathy. To the best of our knowledge, this rare radiological finding has not been<br>reported in medical literature as being associated with hypoxemic respiratory failure in pulmonary TB patients.</p> Dr SHRINATH V, Dr SIDDHARTHA CHAKRABORTY, Dr RAHUL TYAGI, Dr ASHOK NARAYANAN Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1007 Mon, 03 Jun 2024 00:00:00 +0000 Arrhythmia in Adult Congenital Heart Disease https://ojs.ijcp.in/IJCP/article/view/1008 <p>This case report highlights the significance of a multidisciplinary approach in the management of patients with repaired<br>membranous ventricular septal defect (VSD) who develop postoperative arrhythmias. We present the case of a young female<br>who experienced symptomatic episodes of supraventricular tachycardia following VSD repair. Through electrophysiological<br>study and radiofrequency ablation, multiple tachycardia substrates were identified and successfully ablated. This report<br>underscores the importance of combining surgical repair, electrophysiological evaluation and intervention to achieve optimal<br>outcomes in this specific patient population.</p> Dr DEVENDRA SINGH BISHT, Dr KAMAL KISHOR, Dr MOHIT JAIDKA Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1008 Mon, 03 Jun 2024 00:00:00 +0000 An Interesting Case of Chromonychia in an Immunosuppressed Individual https://ojs.ijcp.in/IJCP/article/view/1009 <p>IMAGES IN CLINICAL PRACTICE</p> Dr RAJESH RAJAGOPALAN Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1009 Mon, 03 Jun 2024 00:00:00 +0000 Adolescent Obesity and Type 2 Diabetes Mellitus: Synaptics and Heuristics https://ojs.ijcp.in/IJCP/article/view/1010 <p>The adolescent population is the foundation for a Nation’s progress. Their shoulders therefore must be emboldened with<br>health and dignity to ensure a developed Nation. However, the multitude of prevailing epidemics have left nostone unturned<br>to enfeeble their strength. Type 2 diabetes mellitus (T2DM) and obesity stand amongst the top shotguns. There is a dire need<br>to execute preventive as well as therapeutic actions to contain the epidemic, for which one must be well versed with the<br>attributable risk factors. In this article, we will understand the synaptics of adolescent obesity and T2DM and what strategies<br>are recommended by the health authorities to prevent and overcome this rising epidemic</p> Dr MEENAKSHI VERMA, Dr DAVINDER SINGH BATTH, Dr MOHAN T SHENOY, Dr SUNEET K VERMA Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1010 Mon, 03 Jun 2024 00:00:00 +0000 Medicolegal Insights https://ojs.ijcp.in/IJCP/article/view/1011 <p>MEDICOLEGAL</p> IJCP Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1011 Mon, 03 Jun 2024 00:00:00 +0000 HCFI Dr KK Aggarwal Research Fund https://ojs.ijcp.in/IJCP/article/view/1012 <p>MEDICAL VOICE FOR POLICY CHANGE</p> IJCP Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1012 Mon, 03 Jun 2024 00:00:00 +0000 News and Views https://ojs.ijcp.in/IJCP/article/view/1013 <p>AROUND THE GLOBE</p> IJCP Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1013 Mon, 03 Jun 2024 00:00:00 +0000 Why is Spirituality Well-Being–Friendly? https://ojs.ijcp.in/IJCP/article/view/1014 <p>SPIRITUAL UPDATE</p> IJCP Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1014 Mon, 03 Jun 2024 00:00:00 +0000 Lighter Side of Medicine https://ojs.ijcp.in/IJCP/article/view/1015 <p>LIGHTER READING</p> IJCP Copyright (c) 2024 Indian Journal Of Clinical Practice https://ojs.ijcp.in/IJCP/article/view/1015 Mon, 03 Jun 2024 00:00:00 +0000